期刊文献+

表达IL-4受体的调节性T细胞在过敏性哮喘中的临床意义

Role of regulatory T cells with IL-4R expression in allergic asthma
原文传递
导出
摘要 目的初步探讨表达IL-4受体的调节性T细胞(IL-4R+Treg)在过敏性哮喘中的临床意义。方法本研究纳入对屋尘螨过敏的20例哮喘患者作为研究对象,行肺功能检查和哮喘控制问卷(asthmacontrolquestionnaire,ACQ)调查,20名健康志愿者作为对照组。采用流式细胞术检测外周血IL-4R+Treg/Treg百分比。结果间歇轻度组(n=12)、中重度组(n=8)和正常对照组(n=20)IL-4R+Treg/Treg%分别为(4.24±2.14)%、(14.56±4.19)%和(1.04±0.54)%,各组之间差异有统计学意义(P<0.001)。哮喘组IL-4R+Treg/Treg%与FEV1%预计值呈显著负相关性(r=-0.512,P<0.05),与ACQ得分呈显著正相关性(r=0.592,P<0.01)。结论 Treg表达的IL-4R在过敏性哮喘的免疫反应中可能发挥重要作用,IL-4R+Treg细胞数量的增多可导致哮喘患者体内免疫失衡而促进哮喘的发生发展。 Objective To investigate the clinical significance of regulatory T cells with IL-4R expression (IL-4R+Treg) in allergic asthma.Methods 20 patients with chronic persistent asthma were enrolled, lung function was tested and asthma control questionnaire (ACQ) was recorded.20 healthy donors were enrolled as control. The proportions of IL-4R+Treg in peripheral blood were determined by flow cytometry.Results The percentages of IL-4R+Treg/Treg in peripheral blood with intermittent-mild and moderate-severe asthma were higher than that in healthy controls [(4.24±2.14)% vs (1.04±0.54)%,P<0.001];[(14.56±4.19)% vs (1.04±0.54)%,P<0.001], and intermittent-mild asthma was significantly lower than moderate-severe asthma [(4.24±2.14)% vs (14.56±4.19)%,P<0.001]. The percentage of IL-4R+Treg/Treg in peripheral blood with asthma was negatively associated with FEV1%pred (r=-0.512,P<0.05), and positively associated with the score of ACQ(r=0.592,P<0.01).Conclusions We speculated IL-4R expressed by Treg play an important role in patients with asthma on the immune response, the increased number of IL-4R+Treg resulted in immune response imbalances and promote the occurrence and progress of asthma.
出处 《中华哮喘杂志(电子版)》 CAS 2012年第6期395-398,共4页 Chinese Journal of Asthma(Electronic Version)
基金 上海市自然科学基金基础重点项目(项目编号:08JC1415200)
关键词 过敏性哮喘 调节性T细胞 哮喘控制问卷 Allergic asthma Regulatory T cells Asthma control questionnaire
  • 相关文献

参考文献2

二级参考文献39

  • 1Buckner JH.Mechanisms of impaired regulation by CD4+ CD25+FOXP3+ regulatory T cells in human autoimmune diseases[J].Nat Rev Immunol,2010,10(12):849-859.
  • 2Robinson DS.Regulatory T cells and asthma[J].Clin Exp Allergy,2009,39(9):1314-1323.
  • 3Lewkowich IP,Herman NS,Schleifer KW,et al.CD4+ CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function]J].J Exp Med,2005,202(11):1549-1561.
  • 4Akdis M,Verhagen J,Taylor A,et al.Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells[J].J Exp Med,2004,199 (11):1567-1575.
  • 5Hard D,Koller B,Mehlhom AT,et al.Quantitative and functional impairment of pulmonary CD4+CD25+ regulatory T cells in pediatric asthma[J].J Allergy Clin Immunol,2007,119(5):1258-1266.
  • 6Ling EM,Smith 1",Nguyen XD,et al.Relation of CD4+ CD25+ regulatory T-cell suppression of allergen-driven Tcell activation to atopic status and expression of allergic disease[J].Lancet,2004,363(9409):608-615.
  • 7Wang Y,Souabni A,Flavell RA,et al.An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo[J].J Immunol,2010,185 (10):5983-5992.
  • 8Tang Q,Adams JY,Penaranda C,et al.Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction[J].Immunity,2008,28(5):687-697.
  • 9Schneider A,Rieck M,Sands S,et al.The effector T cells of diabetic subjects axe resistant to regulation via CD4+ FOXP3+ regulatory T cells[J].J Immunol,2008,181(10):7350-7355.
  • 10Pillemer BB,Qi Z,Melgert B,et al.STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells[J].J Immunol,2009,183(1):155-163.

共引文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部